DAB2IP and neoplasm: Loss of tumor-suppressor Disabled homolog 2-interacting protein (DAB2IP) is an independently significant predictor of poor MFS on the basis of pretreatment biopsy among patients treated with RT and ADT according to Jacobs et al. They also suggest that DAB2IP loss might explain the differences in tumor aggressiveness and radiation resistance.